Copd Exacerbation

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results.

Healio Pulmonology has compiled the top news on COPD posted in 2024.

Having GERD, diabetes or osteoporosis in addition to COPD heightened the likelihood for exacerbations, ED visits and hospitalizations, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

When diagnosed with COPD, 86.2% of patients did not receive treatment, and after 4 years, 63.8% still had not been treated, according to results published in BMC Pulmonary Medicine.

PHILADELPHIA — Despite the growing prevalence of wearable devices, more research is needed before they can be used to predict and monitor COPD exacerbations, according to a presentation at the 2024 GOLD COPD International Conference.

BOSTON — Moving from Global Initiative for Chronic Obstructive Lung Disease, or GOLD, group A/B to group E was common among patients starting a new inhaled maintenance medication, according to a presentation at the CHEST Annual Meeting.

The ability of an artificial neural network to predict COPD exacerbations from urine samples was “excellent,” according to results published in ERJ Open Research.

BOSTON — Among adults with COPD, the odds for exacerbations and hospitalizations were elevated in patients who did not use vs. did use the diabetes medication metformin, according to an abstract presented at the CHEST Annual Meeting.

BOSTON — After progressing to Global Initiative for Chronic Obstructive Lung Disease, or GOLD, group E, patients with COPD faced higher costs and used health care resources more, according to a poster presented at the CHEST Annual Meeting.

BOSTON — Patients with COPD using the common muscle relaxants cyclobenzaprine or methocarbamol had increased risk for COPD exacerbations at follow-up, according to data presented at the CHEST Annual Meeting.